These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12942341)

  • 1. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.
    Decousser JW; Pina P; Picot F; Allouch PY
    Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):561-5. PubMed ID: 12942341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
    Critchley IA; Jacobs MR; Brown SD; Traczewski MM; Tillotson GS; Janjic N
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2639-43. PubMed ID: 18443117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
    Hanaki H; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1999 Sep; 52(9):563-70. PubMed ID: 10746191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro bactericidal activities of new oral penem, faropenem against the various clinical isolates].
    Matsuzaki K; Nishiyama T; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 May; 52(5):431-8. PubMed ID: 10480050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of faropenem against resistant isolates of Streptococcus pneumoniae.
    Black JA; Moland ES; Chartrand SA; Thomson KS
    Diagn Microbiol Infect Dis; 2001; 41(1-2):89-92. PubMed ID: 11687320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and bacteriological studies of Streptococcus pneumoniae. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of beta-lactam-resistant strains].
    Oguri T
    Jpn J Antibiot; 1986 Mar; 39(3):783-806. PubMed ID: 3735669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
    Schmitz FJ; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit AC
    J Antimicrob Chemother; 2001 Jul; 48(1):148-52. PubMed ID: 11418531
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area.
    Decousser JW; Ovetchkine P; Collignon A; Chaplain C; Estrangin E; Fremaux A; Reinert P; Foucaud P; Ghnassia JC; Cohen R; Gaudelus J; Allouch PY
    Eur J Clin Microbiol Infect Dis; 2004 Jan; 23(1):27-33. PubMed ID: 14652781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of faropenem activity against anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Bryskier A
    J Chemother; 2005 Feb; 17(1):36-45. PubMed ID: 15828442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
    Decousser JW; Methlouthi I; Pina P; Allouch P;
    J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639
    [No Abstract]   [Full Text] [Related]  

  • 14. Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.
    Goldstein FW
    J Antimicrob Chemother; 1999 Aug; 44(2):141-4. PubMed ID: 10473219
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.
    Stone KC; Dagan R; Arguedas A; Leibovitz E; Wang E; Echols RM; Janjic N; Critchley IA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2230-5. PubMed ID: 17387157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of faropenem against infections in pediatric fields].
    Sunakawa K; Satoh Y; Iwata S; Terashima I; Meguro H; Kusumoto Y; Kato T; Akita H; Goshima T; Yokota T; Toyonaga Y; Ishihara T; Kanemura H; Iwai N; Nakamura H; Nakashima M
    Jpn J Antibiot; 1997 Sep; 50(9):739-55. PubMed ID: 9394235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies on the impact of human serum on the antibacterial effect of faropenem.
    MacGowan A; Bowker K
    J Chemother; 2004 Feb; 16(1):23-9. PubMed ID: 15077995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002].
    Yao KH; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Shen XZ; Yang YH
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1957-61. PubMed ID: 16313770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility patterns of Streptococcus pneumoniae in Mexico.
    Quiñones-Falconi F; Calva JJ; López-Vidal Y; Galicia-Velazco M; Jiménez-Martinez ME; Larios-Mondragón L
    Diagn Microbiol Infect Dis; 2004 May; 49(1):53-8. PubMed ID: 15135501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.